Ambu and Coloplast unaffected by Covid-19 lockdowns in China – for now

The city of Shenzen, which is 200km from Coloplast’s factory in China, has been placed under a comprehensive lockdown.

Photo: PR / Ambu

The Covid-19 infection rate in China is increasing, which has led the country to implement wide-reaching measures – including comprehensive lockdown – to contain the infection.

This has not affected Danish medtech companies Ambu and Coloplast, which both have factories in China – yet.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs